Published 2 years ago

Fauci says he is experiencing ‘rebound’ of COVID symptoms after Paxlovid treatment

Summary by Ground News

Anthony Fauci contracted Covid earlier this month. He was prescribed Paxlovid due to his age -- 81 -- which puts him at high risk of developing complications. He reverted to negative on an antigen test for three days in a row, he said. On the fourth day, just to be ...

0 Articles

All

Left

Center

Right

abc News

Fauci says he's taking 2nd course of Paxlovid after experiencing rebound with the antiviral treatment

Fauci, 81, said that when he first tested positive two weeks ago, he had very minimal symptoms.

2 years ago·United States

Read Full Article

Washington Times

Dr. Anthony Fauci says he suffered Paxlovid ‘rebound’

Dr. Anthony Fauci says he experienced a rebound of COVID-19 symptoms after taking Paxlovid, the antiviral drug from Pfizer.

2 years ago·United States

Read Full Article

New York Post

Dr. Fauci reveals ‘COVID rebound’ after Pfizer’s Paxlovid treatment

Fauci said that he is experiencing “much worse” COVID symptoms after being treated with Pfizer’s antiviral medication Paxlovid.

2 years ago·New York, United States

Read Full Article

The Hill

Fauci says he is experiencing ‘rebound’ of COVID symptoms after Paxlovid treatment

Anthony Fauci, the nation’s top infectious diseases doctor, said he is experiencing a rebound of COVID-19 symptoms after taking Pfizer’s antiviral drug Paxlovid.

2 years ago·Washington, United States

Read Full Article

IBTimes

Fauci Experiencing COVID-19 Symptoms Again After Pfizer's Antiviral Treatment

Anthony Fauci had recently finished a five-day course of Pfizer's antiviral treatment Paxlovid.

2 years ago·United States

Read Full Article

Infobae

Dr. Fauci sufre rebote de síntomas de covid tras tomar Paxlovid

Anthony Fauci, el principal asesor médico del presidente Joe Biden, sufrió un rebote de los síntomas de covid-19 después de tomar el antiviral Paxlovid de Pfizer Inc.

2 years ago·C A B A, Argentina

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.